What Happens When Underperforming Big Ideas in Research Become Entrenched?

Michael J. Joyner; Nigel Paneth; John P A Ioannidis

doi:10.1001/jama.2016.11076

Back

What Happens When Underperforming Big Ideas in Research Become Entrenched?

Article 2016 en

Authors

MJ
Michael J. Joyner
NP
Nigel Paneth
John P A Ioannidis
Stanford University

Abstract

1 min read

In this Viewpoint, John Ioannidis and colleagues review how rarely gene therapy and genomic medicine have led to breakthroughs for patients and call on the NIH to defund preclinical research that fails to deliver on its initial promise.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2008

Acknowledgments

Tanya Agurs‐Collins, Claude Bouchard

Obesity

Letter2009

Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?

John P A Ioannidis

Article2000

Transgenic mouse models in angiogenesis and cardiovascular disease

Peter Carmeliet, D Collen

Article2022

Progress of Genomics-Driven Approaches for Sustaining Underutilized Legume Crops in the Post-Genomic Era

Uday Chand Jha, Harsh Nayyar, Swarup K. Parida, Melike Bakır, Eric von Wettberg, Kadambot Siddique

Article2018

What's new in psoriasis treatment? An analysis of systematic reviews published in 2015

Amy Foulkes, Felicity J. Ferguson, D. J. C. Grindlay, Hywel C Williams, Christopher Em Griffiths, Richard B. Warren